The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

This document is the second of 2 companion appropriate use criteria (AUC) documents
developed by the American College of Cardiology, American Association for Thoracic …

Objective: To examine predictors of stroke recurrence in patients with a high vs a low
likelihood of having an incidental patent foramen ovale (PFO) as defined by the Risk of …

Background and Purpose—Recurrent cerebrovascular events are frequent in medically
treated patients with patent foramen ovale (PFO), but it still remains unclear whether PFO is …

Objectives This study sought to assess patent fossa ovalis (PFO) anatomy by
transesophageal echocardiography (TEE) in patients undergoing percutaneous suture …

Backgrounds Long‐term fate of patients submitted to patent foramen ovale (PFO) closure is
still unclear. The aim of the study was to evaluate the incidence of atrial fibrillation (AF) …

Left atrial (LA) enlargement is a marker of LA cardiopathy and, in patients with patent
foramen ovale (PFO), is associated with an increased risk of ischemic stroke. The primary …

Background Atrial fibrillation is responsible for up to one-third of ischemic strokes, and is
also associated with silent cerebral infarctions and transient ischemic attacks (TIAs). The self …

Background Stroke in association with a patent foramen ovale (PFO) may be due to
paradoxical embolization via a right to left intracardiac shunt but the exact contribution of …

Aims The optimal antiplatelet therapy after atrial septal defect (ASD) or patent foramen ovale
device closure (PFO) remain to be established. We evaluated the safety and effectiveness of …